导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.27% | 513/1050 |
| 近一周 | -1.58% | 249/1104 |
| 近一月 | -10.07% | 1038/1102 |
| 近一季 | 7.59% | 105/1092 |
| 近半年 | 2.03% | 380/1070 |
| 近一年 | -17.97% | 864/1018 |
| 近两年 | 12.38% | 832/926 |
| 近三年 | -15.09% | 755/834 |
| 成立以来 | 8.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.26% 321/1070 |
7.97% 572/1101 |
- - |
- - |
| 2025 | 2.20% 913/1065 |
15.85% 46/1014 |
-1.27% 796/1038 |
7.23% 897/1050 |
-16.66% 1002/1065 |
| 2024 | -22.72% 919/1011 |
-13.43% 874/960 |
-14.86% 937/983 |
17.71% 111/991 |
-10.92% 929/1011 |
| 2023 | -9.23% 307/952 |
1.97% 512/880 |
-2.93% 367/895 |
-10.65% 606/915 |
2.63% 52/952 |
| 2022 | -33.52% 689/867 |
-10.80% 126/773 |
-10.16% 773/806 |
-20.21% 759/845 |
3.97% 245/867 |
| 2021 | 4.25% 313/740 |
10.69% 9/580 |
25.04% 91/659 |
-16.22% 633/704 |
-10.10% 661/740 |
| 2020 | 73.31% 128/554 |
11.92% 35/419 |
41.59% 17/466 |
-4.58% 459/517 |
14.62% 213/554 |
| 2019 | 38.87% 229/410 |
30.56% 345/1146 |
-5.84% 765/1228 |
9.57% 120/390 |
3.10% 370/410 |
| 2018 | -11.09% 12/349 |
- - |
-0.66% 94/990 |
-5.37% 477/1000 |
-9.31% 244/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 金鹰医疗健康产业C VS. 东吴新产业精选股票A(580008) |